DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20161537

To evaluate the analgesic activity of resveratrol in different doses in animal model

Tanu Garg, Vijay Yadav, Rekha Mehani

Abstract


Background: Pain is a complex unpleasant phenomenon composed of sensory experiences originating from damaged tissue or abnormal physiological condition. The objective of this study was to evaluate the analgesic activity of resveratrol in different doses in animal model.

Methods: Albino mice of either sex weighing 20-30 gms were selected for the study. Mice were divided into 4 groups of 6 animals each. The control group received 0.9% normal saline (10 ml/kg), standard group received indomethacin (10 mg/kg) and test groups received resveratrol (50 mg/kg and 100 mg/kg). The drugs were given orally 1 hour prior to the tests. The animals were tested for analgesia activity 30, 60, 90, 120 minutes after drug administration using tail flick method and 1% acetic acid was given intraperitoneally to induce writhing in the other method. Delay in the reaction time in tail flick method and decrease in total number of writhes in acetic acid induced writhing model denoted analgesic activity. Data analysis was done using one way ANOVA followed by Tukey’s HSD test. P<0.05 was considered as statistically significant.

Results: Resveratrol showed significant increase in reaction time at various time periods in tail flick method and showed significant decrease in the number of writhes in acetic acid induced writhing method.

Conclusions: In the study, resveratrol exhibited analgesic activity in both thermal and chemical pain models in both the doses, and analgesic activity in higher dose (100 mg/kg) was comparable to standard drug.


Keywords


Analgesic, Resveratrol, Writhing

Full Text:

PDF

References


Milind P, Monu Y. Laboratory models for screening analgesics. International Research Journal of Pharmacy. 2013;4(1):15-9.

Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Research. 2004;24:2783-840.

Smoliga JM, Baur JA, Hausenblas HA. Resveratrol and health-a comprehensive review of human clinical trials. Mol. Nutr. Food Res. 2011;55:1129-41.

Mishra D, Ghosh G, Kumar PS, Panda PK. An experimental study of analgesic activity of selective cox-2 inhibitor with conventional NSAIDS. Asian Journal of Pharmaceutical and Clinical Research. 2011;4(1):78-81.

Gupta SK. Drug screening methods (Preclinical Evaluation of New Drugs). 2nd edition.

Shanmugasundaram P, Venkataraman S. Anti-nociceptive activity of hygrophila auriculata (Schum) Heine. Afr J Trad. CAM. 2005;2(1):62-9.

Vogel HG. Analgesic, anti-inflammatory, and anti-pyretic activity. In: drug discovery and evaluation: pharmacological assays. 2nd ed. Germany: Springer-Verlag Berlin Heidelberg; 2002:2:669-774.

Pham-Marcou TA, Beloeil H, Sun X, Gentili M, Yaici D, Benoit G, et al. Antinociceptive effect of resveratrol in carrageenan-evoked hyperalgesia in rats: prolonged effect related to COX-2 expression impairment. Pain. 2008;140(2):274-83.

Gentilli M, Mazoit JX, Bouaziz H, Fletcher D, Casper RF, Benhamou D, et al. Resveratrol decreases hyperalgesia induced by carrageenan in the rat hind paw. Life Sci. 2001;68(11):1317-21.